What Are the Molecules Involved in Regulatory T-Cells Induction by Dendritic Cells in Cancer?
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-10
Abstract
Dendritic cells (DCs) are essential for the maintenance of homeostasis in the organism, and they do that by modulating lymphocyte priming, expansion, and response patterns according to signals they receive from the environment. The induction of suppressive lymphocytes by DCs is essential to hinder the development of autoimmune diseases but can be reverted against homeostasis when in the context of neoplasia. In this setting, the induction of suppressive or regulatory T cells contributes to the establishment of a state of tolerance towards the tumor, allowing it to grow unchecked by an otherwise functional immune system. Besides affecting its local environment, tumor also has been described as potent sources of anti-inflammatory/suppressive factors, which may act systemically, generating defects in the differentiation and maturation of immune cells, far beyond the immediate vicinity of the tumor mass. Cytokines, as IL-10 and TGF-beta, as well as cell surface molecules like PD-L1 and ICOS seem to be significantly involved in the redirection of DCs towards tolerance induction, and recent data suggest that tumor cells may, indeed, modulate distinct DCs subpopulations through the involvement of these molecules. It is to be expected that the identification of such molecules should provide molecular targets for more effective immunotherapeutic approaches to cancer.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2009/54599-5, 2011/08905-7)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2009/54599-5, 2011/08905-7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2009/54599-5, 2011/08905-7)
This publication has 101 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Transforming growth factor beta (TGF-β) and inflammation in cancerCytokine & Growth Factor Reviews, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic CellsImmunity, 2008
- Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancerBritish Journal of Cancer, 2007
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004